- Advanced Vision Therapies, Inc. - Company focused on the treatment of sight-threatening eye diseases such as age-related macular degeneration and finding a cure.
- Amsterdam Molecular Therapeutics - Focused on developing gene therapies for lipoprotein lipase disorder, inflammatory bowel disease and neuroregeneration. Also provides contract development and manufacturing of gene and cell-based products in their GMP facility.
- Ark Therapeutics - A gene medicine company developing a broad range of products based on vascular and endothelial molecular biology to treat vascular and circulatory diseases and cancer.
- BioVex - Biotechnology company developing a new class of biologics for the treatment of cancer and prevention of infectious disease. OncoVEX is a cancer destroying virus technology and ImmunoVEX is a vaccine for genital herpes.
- Cell Genesys - Focused on the development and commercialization of cancer vaccines and gene therapies to treat various cancers including leukemia, hemophilia A and B, restenosis after angioplasty and Parkinson's disease.
- Ceregene, Inc. - Pioneering genetic therapies for neurologic disorders.
- Cobra Biomanufacturing - Contract manufacturing organisation focusing on the production of protein, viral and DNA-based therapeutics at cGMP grade.
- Collateral Therapeutics - A product-driven cardiovascular gene therapy company, focused on the discovery, development and commercialization of novel and innovative non-surgical gene therapy products.
- Copernicus Therapeutics, Inc. - Developing human gene therapy products for cystic fibrosis and hemophilia B and DNA vaccinations. The company creates proprietary PLASmin Complexes which are efficient non-viral vectors and REPLIsome vectors which allow replication of non-viral vectors.
- Gene Therapy Systems - Commercial firm providing reagents for gene delivery and gene therapy research, including unique pGeneGrip fluorescently labeled plasmid vectors and GenePORTER cationic lipid transfection reagent.
- GenVec - An emerging biopharmaceutical company developing novel gene therapies for diseases where local delivery of a therapeutic gene has potential benefits over currently available treatments. New product development initiatives have been formalized for coronary artery disease with BioBypass angiogen, restenosis prevention and cancer.
- Henogen - A GMP biomanufacturing company located in Belgium, able to produce, purify and aseptically fill clinical batches of therapeutic proteins, monoclonal antibodies, plasmid DNA, vaccinal viruses or viral vectors for gene therapy.
- Molecular Medicine Bioservices, Inc. - A development and manufacturing company based in San Diego dedicated to the production of high-quality, clinical grade, gene and cell based therapeutics and reagents.
- Nature Technology Corporation - Genetic technology and services company, focusing on plasmid DNA manufacturing, DNA vaccines and genetic vectors.
- Oxford Biomedica - Focuses on developing gene transfer technologies for human gene therapy, gene-based immunotherapy, and gene-based drug discovery for cancer, AIDS, neurodegenerative and cardiovascular disease.
- Puresyn, Inc. - Develops separation and purification processes for manufacturing gene delivery products such as supercoiled plasmids, synthetic oligonucleotides, recombinant adenovirus and adeno-associated virus.
- Transgene S.A. - Gene therapy company based in France is developing products for cancer and cystic fibrosis. Vector platforms include adenovirus, retrovirus, vaccinia virus, cellular and synthetic vectors.
- Vectorite Biomedica Inc. - Company focusing on the development of therapeutic lentivirus vector technology for the delivery of short interfering RNA molecules.
- VirRx, Inc. - A biotechnology company with a primary interest in cancer gene therapy.
Last update: Apr 28, 2012 18:35:11. Phy.org is a private web site, powered by the Open Directory Project.
